FBN1 and Loeys-Dietz syndrome: The fact that neither a panel nor CNV-sequencing (or software equivalent, e.g., ExomeDepth) was used is a significant limitation, since patients with exon deletions or Loeys-Dietz syndrome could have been included in the FBN1 negative group.